Form 4: Telesis Bio Inc. Executive Daniel Glenn Gibson Reports Tax Withholding Transaction

Chief Technology Officer of Telesis Bio Inc., Daniel Glenn Gibson, reports a transaction involving the withholding of shares to cover tax obligations related to vested Restricted Stock Units.

Summary

• On February 27, 2024, Daniel Glenn Gibson, Chief Technology Officer of Telesis Bio Inc., had 2,265 shares of common stock withheld by the issuer to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs).
• The price per share for the withholding was $0.534.
• Following the transaction, Gibson beneficially owns 99,818 shares of Telesis Bio Inc. common stock, some of which are RSUs representing a contingent right to receive one share of common stock each, subject to vesting schedules and conditions.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company stock. It reflects routine transactions related to executive compensation and tax obligations.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard tax withholding.

Key Dates

Keywords

Form 4, Telesis Bio Inc., Daniel Glenn Gibson, TBIO, Chief Technology Officer, RSU, Restricted Stock Units, Tax Withholding, Beneficial Ownership